Glis2 was selected for biological validation based on its robust expression along the entire nephron, its association with a ciliopathic nephronophthisis phenotype and its strong statistical association with the “CDCA pattern” TRAP gene set. The gene discussed is GLIS2; the disease is nephronophthisis.